CVS Health (NYSE:CVS) said Wednesday it maintained its 2023 guidance, including adjusted per-share earnings of $8.50 to $8.70.
Analysts surveyed by Capital IQ expect $8.63.
The company said it reaffirmed its cash flow operations outlook range of $12.50 billion to $13.50 billion and continues to expect more than half of 2023 earnings in the second half of 2023, with Q3 earnings being modestly higher than in Q4.